Drug recall · March 24, 2021
Romidepsin Injecton recall
Why: Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01
- Lots / codes
Lot # 31328184C, exp. date 11/2021 Lot # 31327686C, exp. date 08/2021 Lot # 31327685C, exp. date 08/2021
- Quantity
- 1,416 vials
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Distributed Nationwide in the USA.
- Initiated
- March 4, 2021 · Voluntary: Firm initiated
- Classified
- March 19, 2021
- Reported
- March 24, 2021
- Ended
- May 19, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Romidepsin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.